L.J. Altfest & Co’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$185K	Buy	+13,210	New	+$185K	0.02%	324
2024 Q4	–	Sell	-13,512	Closed	-$307K	–	371
2024 Q3	$307K	Buy	+13,512	New	+$307K	0.04%	273